• No results found

(BaPb)/sub 4/Li/sub 2/Nb/sub 10/O/sub 20/

Biological responses to core–shell-structured Fe3O4@SiO2-NH2 nanoparticles in rats by a nuclear magnetic resonance-based metabonomic strategy

Biological responses to core&ndash;shell-structured Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>-NH<sub>2</sub> nanoparticles in rats by a nuclear magnetic resonance-based metabonomic strategy

... The 20 nm Fe@Si NPs induced more obvious lasting biological responses than 10 or 40 nm Fe@ Si NPs, which implies that it is possible to provide a favor- able viewing window in multimodal imaging by ...

16

Biosafety evaluation of Janus Fe3O4-TiO2 nanoparticles in Sprague Dawley rats after intravenous injection

Biosafety evaluation of Janus Fe<sub>3</sub>O<sub>4</sub>-TiO<sub>2</sub> nanoparticles in Sprague Dawley rats after intravenous injection

... ± 10%, room tem- perature 20 ° C ± 2 ° C, and 12-hour light/dark ...3 O 4 -TiO 2 NPs or TiO 2 NPs, respectively) with six rats in each ...

15

Biocompatibility of magnetic Fe3O4 nanoparticles and their cytotoxic effect on MCF-7 cells

Biocompatibility of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles and their cytotoxic effect on MCF-7 cells

... 3 O 4 nano magnetofluid (0.5, 1.0, 1.5, and 2.0 g/L Fe 3 O 4 ), and a simple magnetic field irradiation group (a negative control group plus magnetic field ...and 4 kW with an output ...

10

Polyetherimide-grafted Fe3O4@SiO2 nanoparticles as theranostic agents for simultaneous VEGF siRNA delivery and magnetic resonance cell imaging

Polyetherimide-grafted Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoparticles as theranostic agents for simultaneous VEGF siRNA delivery and magnetic resonance cell imaging

... g/mL, 10 μ g/mL, 20 μ g/mL, 40 μ g/mL, or 80 μ g/mL of the Fe 3 O 4 @SiO 2 /PEI nanoparticle ...for 2 hours, and then centrifuged for 2 minutes at 4,000 ...

13

Immobilized transferrin Fe3O4@SiO2 nanoparticle with high doxorubicin loading for dual-targeted tumor drug delivery

Immobilized transferrin Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoparticle with high doxorubicin loading for dual-targeted tumor drug delivery

... in 10 mL phosphate-buffered saline (PBS) solution, and incubated with 5 mg EDC and 5 mg NHS for 30 minutes at room ...Then, 20 µ L of hydrazine hydrate solution was added, and the mixture was incubated ...

9

Toxicity evaluation of Gd2O3@SiO2 nanoparticles prepared by laser ablation in liquid as MRI contrast agents in vivo

Toxicity evaluation of Gd<sub>2</sub>O<sub>3</sub>@SiO<sub>2</sub> nanoparticles prepared by laser ablation in liquid as MRI contrast agents in vivo

... [PBS], 10 µ M, 1 µ M, and 100 nM) in DMEM (Dulbecco’s Modified Eagle’s Medium) at 37 ° C, 5% CO 2 ...added 20 µ L of MTT (3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide) ...

11

Effect of Fe3O4-magnetic nanoparticles on acute exercise enhanced KCNQ1 expression in mouse cardiac muscle

Effect of Fe<sub>3</sub>O<sub>4</sub>-magnetic nanoparticles on acute exercise enhanced KCNQ<sub>1</sub> expression in mouse cardiac muscle

... sulfate [SDS], 20% glycerol) containing the protease inhibitor phenylmethanesulfonyl fluoride 0.1 mM/L. We separated 50 µ g of proteins on SDS–polyacrylamide gel electrophoresis 10%. Proteins were ...

8

Vancomycin-modified Fe3O4@SiO2@Ag microflowers as effective antimicrobial agents

Vancomycin-modified Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>@Ag microflowers as effective antimicrobial agents

... 3 O 4 @SiO 2 @Ag microflowers) were rationally designed and prepared to achieve strong bactericidal ability, a wide antimicrobial spectrum, and good ...3 O 4 @SiO 2 @Ag ...

18

Synthesis of composite magnetic nanoparticles&nbsp;Fe3O4&nbsp;with alendronate for osteoporosis treatment

Synthesis of composite magnetic nanoparticles&nbsp;Fe<sub>3</sub>O<sub>4</sub>&nbsp;with alendronate for osteoporosis treatment

... 3 O 4 , Dex/Fe 3 O 4 , and Bis/Dex/Fe 3 O 4 was verified by XRD (Figure ...3 O 4 pattern published by ...3 O 4 and Bis/Dex/ Fe 3 O 4 was ...

12

Fe3O4-based PLGA nanoparticles as MR contrast agents for the detection of thrombosis

Fe<sub>3</sub>O<sub>4</sub>-based PLGA nanoparticles as MR contrast agents for the detection of thrombosis

... 3 O 4 -PLGA NP group and the Fe 3 O 4 -PLGA- cRGD NP ...min, 10 min, 20 min, 30 min, 1 h, 2 h, and 3 h after injection of the ...3 O 4 -PLGA or Fe 3 O ...

14

The effect of magnetic nanoparticles of Fe3O4 on immune function in normal ICR mice

The effect of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> on immune function in normal ICR mice

... = 10 per ...3 O 4 -MNPs, were dissolved in normal saline and intravenously (iv) injected into mice ...at 4 ° C to separate plasma and blood ...

7

Effect of Alkaline and Alkaline Earth Metal Oxides Addition on the Glass Formation and Crystallization of ZnO Al2O3 SiO2 Glasses

Effect of Alkaline and Alkaline Earth Metal Oxides Addition on the Glass Formation and Crystallization of ZnO Al<sub>2</sub>O<sub>3</sub> SiO<sub>2</sub> Glasses

... wide [16]. It is true that the mobility of network-modifying cation controls the composition and structure of nucleating phases which implies that viscosity controlled by network formers is not an important parameter for ...

13

Sub-10 nm Cu5FeS4 cube for magnetic resonance imaging-guided photothermal therapy of cancer

Sub-10 nm Cu<sub>5</sub>FeS<sub>4</sub> cube for magnetic resonance imaging-guided photothermal therapy of cancer

... FeS 4 group (Figure 8A, left-center and right-center, ...FeS 4 group is little slow (Figure 8B, red and green line, respectively), indicating that the laser or Cu 5 FeS 4 alone has only a minimal ...

10

Combination of PEI-Mn0.5Zn0.5Fe2O4 nanoparticles and pHsp 70-HSV-TK/GCV with magnet-induced heating for treatment of hepatoma

Combination of PEI-Mn<sub>0.5</sub>Zn<sub>0.5</sub>Fe<sub>2</sub>O<sub>4</sub> nanoparticles and pHsp 70-<em>HSV</em>-<em>TK</em>/GCV with magnet-induced heating for treatment of hepatoma

... by 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis and transferred onto polyvinylidene fluoride ...at 4° C overnight, then incubated with secondary antibody for 1 ...

15

Synthesis of Light Hydrocarbons via Oxidative Coupling of Methane over Silica supported Na2WO4 TiO2 Catalyst

Synthesis of Light Hydrocarbons via Oxidative Coupling of Methane over Silica supported Na<sub>2</sub>WO<sub>4</sub> TiO<sub>2</sub> Catalyst

... these two gases are released into the atmosphere. Since methane is an abundant compound on Earth, a process that can convert methane to high value-added chemicals is a highly attractive topic for many researchers. One of ...

14

In vitro toxicity of FemOn, FemOn-SiO2 composite, and SiO2-FemOn core-shell magnetic nanoparticles

In vitro toxicity of Fe<sub>m</sub>O<sub>n</sub>, Fe<sub>m</sub>O<sub>n</sub>-SiO<sub>2</sub> composite, and SiO<sub>2</sub>-Fe<sub>m</sub>O<sub>n</sub> core-shell magnetic nanoparticles

... -Fe 2 O 3 . Using TEM characterization, Fe m O n -SiO 2 composite flake-like and SiO 2 -Fe m O n core-shell IONPs demonstrated spherical shape with mean diameter of 98 ± 22 and ...

11

Preparation of Fe3O4 magnetic nanoparticles coated with gallic acid for drug delivery

Preparation of Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles coated with gallic acid for drug delivery

... The differential thermogravimetric curves indicate the onset of weight loss at 264 ° C (41.0%) and 325 ° C (22.5%). The curved shape of the thermogravimetric-derivative thermogravimetric thermograms changed due to the ...

12

Effect of interaction of magnetic nanoparticles of Fe3O4 and artesunate on apoptosis of K562 cells

Effect of interaction of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> and artesunate on apoptosis of K562 cells

... 3 O 4 was kindly supplied by the state Key Laboratory of Bioelectronics, Southeast University, Nanjing, China, and was well distributed in ...3 O 4 colloidal ...3 O 4 , at the ...

8

Oxygen-Ozone (O2-O3) Therapy in Peripheral Arterial Disease (PAD): A Review Study

<p>Oxygen-Ozone (O<sub>2</sub>-O<sub>3</sub>) Therapy in Peripheral Arterial Disease (PAD): A Review Study</p>

... transport 4 translocation from the intracellular compartment to the cellular ...− 2 /NO − 3 ratio, a marker of nitric ...that O 2 -O 3 therapy ...

16

Retrospective analysis of a lactose breath test in a gastrointestinal symptomatic population of Northeast Italy: use of (H2+2CH4) versus H2 threshold

Retrospective analysis of a lactose breath test in a gastrointestinal symptomatic population of Northeast Italy: use of (H<sub>2</sub>+2CH<sub>4</sub>) versus H<sub>2</sub> threshold

... H 2 Breath Test Kit for the determination of lactose intoler- ance (Sofar SpA, Milan, Italy) was used for the assay, and a standard procedure furnished by the kit manufacturer was ...for 4 hours and ...

6

Show all 10000 documents...

Related subjects